China Biologic Profile

USD 2.33  2.88%

China Biologic Summary

China Biologic Products Inc (CBPO) is traded on NASDAQ in USA. It is located in CHINA and employs 1,751 people. China Biologic is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 2.68 B. China Biologic Products Inc conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 33.13 M outstanding shares of which 1.09 M shares are currently shorted by private and institutional investors with about 2.69 trading days to cover. China Biologic Pr currently holds about 216.45 M in cash with 108.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.84.
Check China Biologic Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Capital Research Global InvestorsCommon Shares3.3 M258.4 M
Baillie Gifford CoCommon Shares1.3 M106.2 M
View China Biologic Diagnostics

Selected China Biologic Products Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

China Biologic Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 48% 
Equity ratings for China Biologic Products Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the Peoples Republic of China. China Biologic Products Holdings, Inc. is headquartered in Beijing, the Peoples Republic of China. China Biologic operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 1751 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameChina Biologic Products Inc
ChairmanDavid GaoAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business AddressJialong International Tower
Foreign Associate  Mexico
CIK Number01369868.0
IndustryPharmaceuticals And Biosciences
Contact Number86 10 6598 3111
CurrencyUSD - US Dollar

Did you try this?

Run Portfolio Quick Import Now

Portfolio Quick Import

Import or update all your transactions via one easy-to-use interface
Hide  View All  NextLaunch Portfolio Quick Import


China Biologic Analyst Recommendations
Target PriceAdvice# of Analysts
142.33Strong Buy3Odds
China Biologic Products Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
China Biologic Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


China Biologic Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.36May 3, 2017
China Biologic Products Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


China Biologic Corporate Directors
Min Fang Director, MBA
Joseph Chow Independent Director, MBA
Xiaosheng Shao Independent Director